Atrion Corporation (ATRI)

Etorro trading 970x250
Atrion Corporation (ATRI) Logo

About Atrion Corporation

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Germany, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company’s cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, mixes critical drugs, controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas. Address: One Allentown Parkway, Allen, TX, United States, 75002-4211

Atrion Corporation News and around…

Latest news about Atrion Corporation (ATRI) common stock and company :

Investing in Atrion (NASDAQ:ATRI) five years ago would have delivered you a 65% gain
19 Oct, 2021 Yahoo! Finance

If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see...

Atrion Corporation (NASDAQ:ATRI) Will Pay A US$1.95 Dividend In Two Days
11 Sep, 2021 Yahoo! Finance

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Atrion...

Atrion (NASDAQ:ATRI) Will Pay A Larger Dividend Than Last Year At US$1.95
07 Sep, 2021 Yahoo! Finance

Atrion Corporation's ( NASDAQ:ATRI ) dividend will be increasing to US$1.95 on 30th of September. This takes the annual...

Atrion Corporation Announces Election of New Director
30 Aug, 2021 FinancialContent
Atrion Corporation Increases Quarterly Cash Dividend by 11%
30 Aug, 2021 FinancialContent
Is Atrion Corporation's (NASDAQ:ATRI) Shareholder Ownership Skewed Towards Insiders?
21 Aug, 2021 Yahoo! Finance

The big shareholder groups in Atrion Corporation ( NASDAQ:ATRI ) have power over the company. Large companies usually...

Wall Street ignores these ‘orphan’ stocks, but they’ve beaten the S&P 500 over 20 years
18 Aug, 2021 FinancialContent

A business might be considered boring, but a solid operator can make owners of its stock a lot of money while flying under the radar.

Atrion Reports Second Quarter Results
09 Aug, 2021 FinancialContent
Atrion (NASDAQ:ATRI) Is Reinvesting At Lower Rates Of Return
15 Jul, 2021 Yahoo! Finance

There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...

Only Four Days Left To Cash In On Atrion's (NASDAQ:ATRI) Dividend
09 Jun, 2021 Yahoo! Finance

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Atrion Corporation Declares Quarterly Cash Dividend
21 May, 2021 FinancialContent
Why We Think Atrion Corporation's (NASDAQ:ATRI) CEO Compensation Is Not Excessive At All
15 May, 2021 Yahoo! Finance

Performance at Atrion Corporation ( NASDAQ:ATRI ) has been rather uninspiring recently and shareholders may be...

Atrion Reports First Quarter Results
10 May, 2021 FinancialContent
Atrion Reports First Quarter Results
10 May, 2021 Yahoo! Finance

ALLEN, Texas, May 10, 2021 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq - ATRI) today announced that revenues for the quarter ended March 31, 2021 were $39.2 million compared with $43.6 million for the first quarter of 2020. Net income in the current-year quarter totaled $7.7 million compared to $8.9 million in last year’s first quarter, with diluted earnings per share for the first quarter of 2021 at $4.22 compared to $4.79 for the first quarter of 2020. Commenting on results for the first quarter of 2021 and the outlook for the remainder of 2021, Mr. Battat stated, “I am very pleased to report strong growth in quarterly sequential sales, with revenues for the first quarter of 2021 increasing by $7.0 million compared to the preceding quarter. After three successive quarters of sales declines in 2020 during the pandemic we have turned the corner. Our customers are placing increased orders, reflecting the pent-up demand for postponed inpatient and outpatient procedures. Given the easing of quarantine restrictions and the increased availability of vaccines, we expect a continued ramp-up in the number of elective surgeries in each of the remaining quarters of this year, albeit at a modest pace in the second quarter as many people will choose to travel in the late spring and early summer months. As a result, we are confident in our outlook for 2021 and expect revenues in the second half of the year and beyond to continue on a growth path.” Addressing comparisons with the first quarter of 2020, Mr. Battat added, “While the effect of COVID-19 on revenues is diminishing, we are continuing to employ enhanced safety measures in our facilities to protect our workforce, even though this impacts our efficiency and skews pre-pandemic comparisons. Moreover, we have addressed the added financial burdens facing our employees due to the pandemic for expenses such as child care and remote schooling by increasing pay for our manufacturing employees. These cost increases, which we incurred in the just-completed first quarter and are continuing, are the primary reason why gross margins declined from 46% of sales in the first quarter of 2020 to 42% in the just completed quarter of 2021. Nevertheless, operating income in the first quarter of 2021 was a very strong 23% of sales.” Mr. Battat concluded, “Cash and short and long term investments increased slightly to $88.5 million, and we remain debt free.” Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com. Statements in this press release that are forward looking are based upon current expectations and actual results or future events may differ materially. Such statements include, but are not limited to, Atrion's expectations regarding a continued increase in elective surgeries in each of the remaining quarters of 2021 and revenues in the second half of 2021 to continue on a growth path. Words such as "expects," "believes," "anticipates," "forecasts," "intends," "should", "plans," "will" and variations of such words and similar expressions are intended to identify such forward-looking statements. Forward-looking statements contained herein involve numerous risks and uncertainties, and there are a number of factors that could cause actual results or future events to differ materially, including, but not limited to, the following: the risk that the COVID-19 pandemic continues to lead to material delays and cancellations of, or reduced demand for, procedures in which our products are utilized; curtailed or delayed capital spending by hospitals and other healthcare providers; disruption to our supply chain; closures of our facilities; delays in training; delays in gathering clinical evidence; diversion of management and other resources to respond to the COVID-19 outbreak; the impact of global and regional economic and credit market conditions on healthcare spending; the risk that the COVID-19 virus continues to disrupt local economies and to cause economies in our key markets to enter prolonged recessions; changing economic, market and business conditions; acts of war or terrorism; the effects of governmental regulation; the impact of competition and new technologies; slower-than-anticipated introduction of new products or implementation of marketing strategies; implementation of new manufacturing processes or implementation of new information systems; our ability to protect our intellectual property; changes in the prices of raw materials; changes in product mix; intellectual property and product liability claims and product recalls; the ability to attract and retain qualified personnel; and the loss of, or any material reduction in sales to, any significant customers. In addition, assumptions relating to budgeting, marketing, product development and other management decisions are subjective in many respects and thus susceptible to interpretations and periodic review which may cause us to alter our marketing, capital expenditures or other budgets, which in turn may affect our results of operations and financial condition. The foregoing list of factors is not exclusive, and other factors are set forth in the Company's filings with the Securities and Exchange Commission. The forward-looking statements in this press release are made as of the date hereof, and we do not undertake any obligation, and disclaim any duty, to supplement, update or revise such statements, whether as a result of subsequent events, changed expectations or otherwise, except as required by applicable law. Contact:Jeffery Strickland Vice President and Chief Financial Officer (972) 390-9800 ATRION CORPORATIONCONSOLIDATED STATEMENTS OF INCOME(In thousands, except per share data)(Unaudited) Three Months EndedMarch 31, 2021 2020 Revenues$ 39,169 $ 43,594 Cost of goods sold 22,830 23,726 Gross profit 16,339 19,868 Operating expenses 7,408 8,154 Operating income 8,931 11,714 Interest and dividend income 217 462 Other investment income (loss) 62 (997)Other income 66 -- Income before income taxes 9,276 11,179 Income tax provision (1,550) (2,281) Net income 7,726 8,898 Income per basic share$ 4.23 $ 4.80 Weighted average basic shares outstanding 1,826 1,853 Income per diluted share$ 4.22 $ 4.79 Weighted average diluted shares outstanding 1,832 1,859 ATRION CORPORATIONCONSOLIDATED BALANCE SHEETS(In thousands) Mar. 31, Dec. 31,ASSETS2021 2020 (Unaudited) Current assets: Cash and cash equivalents$ 29,427 $ 22,450Short-term investments 18,393 19,258Total cash and short-term investments 47,820 41,708Accounts receivable 20,235 16,445Inventories 49,519 50,298Prepaid expenses and other 2,385 3,868Total current assets 119,959 112,319Long-term investments 40,672 46,207Property, plant and equipment, net 94,891 94,935Other assets 13,321 13,429 $ 268,843 $ 266,890 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities 10,777 13,636Line of credit -- --Other non-current liabilities 13,315 12,812Stockholders’ equity 244,751 240,442 $ 268,843 $ 266,890

The Atrion (NASDAQ:ATRI) Share Price Is Up 62% And Shareholders Are Holding On
12 Apr, 2021 Yahoo! Finance

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd...

Atrion Corporation (NASDAQ:ATRI) Pays A US$1.75 Dividend In Just Four Days
07 Mar, 2021 Yahoo! Finance

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Atrion...

Do Institutions Own Atrion Corporation (NASDAQ:ATRI) Shares?
27 Feb, 2021 Yahoo! Finance

Every investor in Atrion Corporation ( NASDAQ:ATRI ) should be aware of the most powerful shareholder groups. Large...

Atrion Reports Results for Fourth Quarter and Full Year 2020
26 Feb, 2021 FinancialContent
Did Atrion Corporation (NASDAQ:ATRI) Insiders Buy Up More Shares?
28 Jan, 2021 Yahoo! Finance

We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...

Is Atrion Corporation's (NASDAQ:ATRI) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
29 Dec, 2020 Yahoo! Finance

Atrion's (NASDAQ:ATRI) stock is up by a considerable 6.9% over the past month. Given that the market rewards strong...

Is ATRI A Good Stock To Buy Now?
10 Dec, 2020 Yahoo! Finance

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than 817 world-class investment firms that we track and now have access to the collective wisdom contained in […]

How Should Investors React To Atrion's (NASDAQ:ATRI) CEO Pay?
26 Nov, 2020 Yahoo! Finance

David Battat has been the CEO of Atrion Corporation (NASDAQ:ATRI) since 2011, and this article will examine the...

Stocks That Hit 52-Week Lows On Monday
23 Nov, 2020 FinancialContent

Before 10 a.m. ET on Monday, 4 companies set new 52-week lows. Points of Interest: The company with the largest ...

Atrion Reports Third Quarter Results
09 Nov, 2020 FinancialContent

Atrion Corporation (ATRI) is a NASDAQ Common Stock listed in , ,

970x250